Javascript must be enabled to continue!
Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP
View through CrossRef
Abstract
Immune thrombocytopenias are usually associated with normal or increased numbers of megakaryocytes in the marrow. Therefore, the mechanism(s) responsible for the destruction of circulating platelets may not affect megakaryocytes in the same way. One of the possibilities which could account for the differential effect on the cells would be the development of antibodies to components of platelet membranes which are not exposed on the surface of all megakaryocytes. To investigate this possibility, a rabbit antiserum specific for mouse platelets was tested against fresh and cultured mouse megakaryocytes by indirect immunofluorescence. This antiserum cross-reacted with 46% of fresh murine megakaryocytes and 54% of cultured megakaryocytes. Phase- contrast microscopy revealed the reacting megakaryocytes to be fully granulated with irregular contours and in the process of releasing platelets. Nonreactive megakaryocytes demonstrated smooth contours and lacked morphological evidence of thrombocytopoiesis. Electron microscopy showed that only in megakaryocytes (MK) with an irregular contour had the demarcation membrane system (DMS) reached continuity with the plasma membrane. Ultrastructural analysis of megakaryocytes from patients with ITP showed approximately 25% to 50% of megakaryocytes without evidence of injury, whereas 50% to 75% had extensive damage. In undamaged cells, platelet territories had not yet reached the peripheral zone. The DMS of damaged megakaryocytes opened to the exterior elaborating platelets. The observations suggested that some platelet antibodies react only with megakaryocytes which have reached the stage of thrombocytopoiesis. Relevant target antigens may not be exposed on all megakaryocytes before cytoplasmic fragmentation occurs.
Title: Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP
Description:
Abstract
Immune thrombocytopenias are usually associated with normal or increased numbers of megakaryocytes in the marrow.
Therefore, the mechanism(s) responsible for the destruction of circulating platelets may not affect megakaryocytes in the same way.
One of the possibilities which could account for the differential effect on the cells would be the development of antibodies to components of platelet membranes which are not exposed on the surface of all megakaryocytes.
To investigate this possibility, a rabbit antiserum specific for mouse platelets was tested against fresh and cultured mouse megakaryocytes by indirect immunofluorescence.
This antiserum cross-reacted with 46% of fresh murine megakaryocytes and 54% of cultured megakaryocytes.
Phase- contrast microscopy revealed the reacting megakaryocytes to be fully granulated with irregular contours and in the process of releasing platelets.
Nonreactive megakaryocytes demonstrated smooth contours and lacked morphological evidence of thrombocytopoiesis.
Electron microscopy showed that only in megakaryocytes (MK) with an irregular contour had the demarcation membrane system (DMS) reached continuity with the plasma membrane.
Ultrastructural analysis of megakaryocytes from patients with ITP showed approximately 25% to 50% of megakaryocytes without evidence of injury, whereas 50% to 75% had extensive damage.
In undamaged cells, platelet territories had not yet reached the peripheral zone.
The DMS of damaged megakaryocytes opened to the exterior elaborating platelets.
The observations suggested that some platelet antibodies react only with megakaryocytes which have reached the stage of thrombocytopoiesis.
Relevant target antigens may not be exposed on all megakaryocytes before cytoplasmic fragmentation occurs.
Related Results
Hepatitis C Associated ITP: High Incidence of Autoantibodies Specific to Platelet Glycoproteins and Favorable Response to IL-11.
Hepatitis C Associated ITP: High Incidence of Autoantibodies Specific to Platelet Glycoproteins and Favorable Response to IL-11.
Abstract
BACKGROUND. ITP is an autoimmune disorder in which autoantibodies (Ab) reacting to platelet glycoproteins (Gp) mediate immune destruction of platelets. In m...
Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP
Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP
Immune thrombocytopenias are usually associated with normal or increased numbers of megakaryocytes in the marrow. Therefore, the mechanism(s) responsible for the destruction of cir...
Newly Diagnosed Primary Immune Thrombocytopenia in Children: Which Guideline to Adhere?
Newly Diagnosed Primary Immune Thrombocytopenia in Children: Which Guideline to Adhere?
Background: Immune thrombocytopenia purpura (ITP) is an autoimmune disorder of bleeding which is defined as having thrombocytopenia (platelet count below 100.000/µL). Most ITP case...
Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)
Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)
Background and aim: Immune thrombocytopenia (ITP) is the most common bleeding condition in children. Its prognosis is mostly superior, however, severe refractory disease remains di...
Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences
Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences
Background: Immune thrombocytopenia (ITP) is the most common cause of acquired immune platelet destruction in children. Clinical symptoms range from asymptomatic to significant and...
Post‐varicella thrombocytopenic purpura
Post‐varicella thrombocytopenic purpura
AbstractAims: The aim of the study was to characterize the clinical course of post‐varicella idiopathic thrombocytopenic purpura (ITP) and to asses the risk of acquiring ITP after...
Partitioning of Circulating Monocyte Subsets in Immune Thrombocytopenia
Partitioning of Circulating Monocyte Subsets in Immune Thrombocytopenia
Introduction
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by accelerated platelet destruction with impaired platelet production leading to a ...
Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia
Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia
Background
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by increased risk of bleeding, as well as thromboembolic event. ITP as well as the c...

